A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children

Abstract

How to obtain copies of this and other HTA programme reports An electronic version of this title, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable DVD is also available (see below).Printed copies of HTA journal series issues cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our despatch agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per issue and for the rest of the world £3 per issue. How to order:-fax (with credit card details) -post (with credit card details or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you to either print out your order or download a blank order form. Contact details are as follows:Synergie UK (HTA Department) Digital House, The Loddon Centre Wade Road Basingstoke Hants RG24 8QW Email: orders@hta.ac.uk Tel: 0845 812 4000 -ask for 'HTA Payment Services' (out-of-hours answer-phone service) Fax: 0845 812 4001 -put 'HTA Order' on the fax header Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to University of Southampton and drawn on a bank with a UK address.Paying by credit card You can order using your credit card by phone, fax or post. SubscriptionsNHS libraries can subscribe free of charge. Public libraries can subscribe at a reduced cost of £100 for each volume (normally comprising 40-50 titles). The commercial subscription rate is £400 per volume (addresses within the UK) and £600 per volume (addresses outside the UK). Please see our website for details. Subscriptions can be purchased only for the current or forthcoming volume.How do I get a copy of HTA on DVD?Please use the form on the HTA website (www.hta.ac.uk/htacd/index.shtml). HTA on DVD is currently free of charge worldwide.The website also provides information about the HTA programme and lists the membership of the various committees. HTAA 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children Declaration of competing interests: Vaccines used in the original study were manufactured by GlaxoSmithKline and Baxter, both of which donated the vaccine, but had no role in study planning or conduct. The vaccine used in this follow-on study was manufactured by GlaxoSmithKline, from whom it was purchased. AJP, AF, PTH and SF act as chief or principal investigators for clinical trials conducted on behalf of their respective NHS trusts and/or universities, sponsored by vaccine manufacturers, but receive no personal payments from them. KH has been an investigator for clinical trials sponsored by vaccine manufacturers, but received no personal payments from them. AJP, AF, PTH and SF have participated in advisory boards for vaccine manufacturers, but receive no personal payments for this work. MDS, PTH, SF, KH and AF have received financial assistance from vaccin...

Hemagglutination inhibiting antibody persistence 1 year after influenza vaccination in Korean children and adolescents

“…Pandemic influenza vaccines were suggested to provide seroprotective antibody levels against A/H1N1 influenza disease for up to 1 y after immunization in children. 13,15 This paper is the first to study and compare the immunogenicity of 2 different inactivated influenza vaccines for one year in healthy children. When we considered pure vaccine effects, there was no difference of immunity between split and subunit vaccines in the subjects without serological infections during a one year follow up.…”

Pandemic influenza A (H1N1) 2009 vaccination in children: A UK perspective

“…Antibody titres wane after vaccination. In a UK study, conducted in November and December 2010, 1 year after a two‐dose regimen of pandemic influenza vaccine, nearly all children who had received the AS03‐adjuvanted vaccine still had antibody titres above the putatively protective thresholds (microneutralisation titre ≥1:40, HI titre ≥1:32) . However, in these children, geometric mean titres for HI had declined to around 30% of the value seen 3 weeks after vaccination.…”

“…The 2010/2011 trivalent seasonal influenza vaccine, given to children who had received two doses of pandemic influenza vaccine 1 year earlier, produced a marked serological response to the H1N1 component of the vaccine, with a greater than 10‐fold rise in HI geometric mean titre …”